Filing Details

Accession Number:
0001214659-15-007703
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-11-12 16:21:39
Reporting Period:
2015-11-11
Filing Date:
2015-11-12
Accepted Time:
2015-11-12 16:21:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1316175 Anthera Pharmaceuticals Inc ANTH Pharmaceutical Preparations (2834) 201852016
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1314902 Colin Hislop 25801 Industrial Blvd Suite B
Hayward CA 94545
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-11-11 5,000 $5.38 19,147 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,897 Indirect By the Hislop-Burton Family Trust